NF-023
NF-023
NF-023 is a chemical compound known for its role as a selective antagonist of the P2X receptor, a type of purinergic receptor. This compound has been utilized in various research studies to explore the physiological and pathological roles of P2X receptors in the human body.
Chemical Structure and Properties[edit | edit source]
NF-023 is a suramin analogue, which means it shares structural similarities with suramin, a well-known pharmaceutical agent. The chemical structure of NF-023 allows it to interact specifically with P2X receptors, inhibiting their function. This specificity makes NF-023 a valuable tool in pharmacological research.
Mechanism of Action[edit | edit source]
NF-023 functions by binding to P2X receptors, which are ligand-gated ion channels activated by extracellular ATP. By blocking these receptors, NF-023 prevents the influx of cations such as calcium and sodium, thereby modulating cellular responses to ATP. This action is particularly useful in studying the role of P2X receptors in various physiological processes, including neurotransmission, inflammation, and pain perception.
Applications in Research[edit | edit source]
NF-023 has been extensively used in experimental settings to:
- Investigate the role of P2X receptors in the central and peripheral nervous systems.
- Study the involvement of P2X receptors in inflammatory responses and immune cell activation.
- Explore potential therapeutic targets for conditions such as chronic pain, neurodegenerative diseases, and cardiovascular disorders.
Pharmacological Significance[edit | edit source]
The ability of NF-023 to selectively inhibit P2X receptors without affecting other purinergic receptors makes it a significant compound in pharmacological research. It provides insights into the development of new therapeutic agents that target specific subtypes of P2X receptors, potentially leading to treatments with fewer side effects.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety profile of NF-023 is primarily established in controlled laboratory settings. Researchers must handle NF-023 with care, following appropriate safety protocols to minimize exposure and potential risks.
Also see[edit | edit source]
Template:Receptor pharmacology
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
